17β-Estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level

International Journal of Cardiology

Volumn 96, Issue 2, 2004, Pages 223-227

  Dai, Zhong ^a   Zhu, Hui Qing ^a   Jiang, De Jian ^a   Jiang, Jun Ling ^a   Deng, Han Wu ^a   Li, Yuan Jian ^a  

^a Ctrl S Univ Xiangya Med College   (China)

Author keywords

17 Estradiol; Asymmetric dimethylarginine; Endothelium; Low density lipoprotein

Indexed keywords

ACETYLCHOLINE; ESTRADIOL; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; ARGININE; DRUG DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM INJURY; HORMONE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASODILATATION; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; PROBABILITY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM;

ANALYSIS OF VARIANCE; ANIMALS; AORTA, THORACIC; ARGININE; CHOLESTEROL, LDL; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; MALE; MALONDIALDEHYDE; NITRIC OXIDE SYNTHASE; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY;

EID: 3242777032     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.07.012     Document Type: Article

References (39)

1. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease. N. Engl. J. Med. 325:1991;756-762
2. Peng C.F., Li Y.J., Deng H.W., et al. Protective effects of 17beta-estradiol on endothelial function injured by oxidized low-density lipoproteins. Acta Pharmacol. Sin. 17:1996;252-255
3. Negre-Salvayre A., Pieraggi M.T., Mabile L., et al. Protective effect of 17beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 99:1993;207-217
4. Chin-Dusting J.P., Fisher L.J., Lewis T.V., et al. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br. J. Pharmacol. 133:2001;595-605
5. Shaw L., Taggart M.J., Austin C. Mechanisms of 17beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries. Br. J. Pharmacol. 129:2000;555-565
6. Thibodeau P.A., Kachadourian R., Lemay R., et al. In vitro pro- and antioxidant properties of estrogens. J. Steroid Biochem. Mol. Biol. 81:2002;227-236
7. Chang M.Y., Lees A.M., Lees R.S. Low-density lipoprotein modification and arterial wall accumulation in a rabbit model of atherosclerosis. Biochemistry. 32:1993;8518-8524
8. Hein T.W., Kuo L. LDL impair vasomotor function of the coronary microcirculation: role of superoxide anions. Circ. Res. 83:1998;404-414
9. Böger R.H., Bode-Böger S.M., Szuba A., et al. Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 98:1998;1842-1847
10. Böger R.H., Bode-Böger S.M., Sydow K., et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20:2000;1557-1564
11. Yu X.J., Li Y.J., Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci. 54:1994;753-758
12. Bode-Böger S.M., Böger R.H., Kienke S., et al. Elevated L-arginine/dimethylarginie ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem. Biophys. Res. Commun. 219:1996;598-603
13. Böger R.H., Sydow K., Borlak J., et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ. Res. 87:2000;99-105
14. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultra-centrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1955;1345-1353
15. Lowry O.H., Rosebroough N.J., Farr A.L., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265
16. G-dimethylarginine in human plasma by high-performance liquid Chromatography. J. Chromatogr., B, Biomed. Sci. Appl. 692:1997;467-471
17. Bessman J.D., Gardner F.H. Platelet size in thrombocytopenia due to sepsis. Surg. Gynecol. Obstet. 156:1983;177-180
18. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340:1999;1801-1811
19. Nathan L., Chaudhuri G. Estrogens and atherosclerosis. Annu. Rev. Pharmacol. Toxicol. 37:1997;477-515
20. Enderle M.D., Sayer R., Balletshofer B., et al. Acute improvement of peripheral endothelial function in postmenopausal women with coronary artery disease after single oral intake of 17beta-estradiol valerate. Exp. Clin. Endocrinol. Diabetes. 108:2000;382-385
21. Chandrasekar B., Nattel S., Tanguay J.F. Coronary artery endothelial protection after local delivery of 17beta-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function. J. Am. Coll. Cardiol. 38:2001;1570-1576
22. Keaney J.F. Jr., Shwaery G.T., Xu A., et al. 17Beta-estradiol preserves endothelial vasodilator function and limits low-densitylipoprotein oxidation in hypercholesterolemic swine. Circulation. 89:1994;2251-2259
23. Nascimento C.A., Kauser K., Rubanyi G.M. Effect of 17beta-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. Am. J. Physiol. 276(5 Pt 2):1999;H1788-H1794
24. Wagner J.D., Zhang L., Williams J.K., et al. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. Arterioscler. Thromb. Vasc. Biol. 16:1996;1473-1480
25. Rubio-Gayosso I., Sierra-Ramirez A., Garcia-Vazquez A., et al. 17Beta-estradiol increases intracellular calcium concentration through a short-term and nongenomic mechanism in rat vascular endothelium in culture. J. Cardiovasc. Pharmacol. 36:2000;196-202
26. Sherman T.S., Chambliss K.L., Gibson L.L., et al. Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am. J. Respir. Cell Mol. Biol. 26:2002;610-616
27. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA. 288:2002;49-57
28. Reis S.E., Bhoopalam V., Zell K.A., et al. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts. Circulation. 97:1998;23-25
29. Fricchione G.L., Bilfinger T.V., Hartman A., et al. Neuroimmunologic implications in coronary artery disease. Adv. Neuroimmunol. 6:1996;131-142
30. Mikkola T.S., Clarkson T.B. Estrogen replacement theory, atherosclerosis, and vascular function. Cardiovasc. Res. 53:2002;605-619
31. Xiong Y., Li Y.J., Yu X.J., et al. Endogenous inhibitor of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits. Acta Pharmacol. Sin. 17:1996;149-152
32. Böger R.H., Bode-Böger S.M. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin. Thromb. Hemost. 26:2000;539-545
33. Ito A., Tsao P.S., Adimoolam S., et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 99:1999;3092-3095
34. Calara F., Dimayuga P., Niemann A., et al. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler. Thromb. Vasc. Biol. 18:1998;884-893
35. Teerlink T., Neele S.J., De Jong S., et al. Estrogen replacement therapy lowers plasma levels of asymmetric dimethylarginine in healthy postmenopausal women. Clin. Sci. (Lond.). 2003 (Mar 7);. [electronic publication ahead of print]
36. Xiong Y., Yuan L.W., Deng H.W., et al. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 28:2001;842-847
37. Jiang J.L., Li N.S., Li Y.J., et al. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Br. J. Pharmacol. 135:2002;1175-1182
38. Mooradian A.D. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45:1993;509-511
39. Kuohung W., Shwaery G.T., Keaney J.F. Jr. Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cells. Am. J. Obstet. Gynecol. 184:2001;1060-1063